新型含咔唑环酰腙衍生物的合成及Cdc25B/PTP1B抑制活性评价
收稿日期: 2018-06-27
修回日期: 2018-08-22
网络出版日期: 2018-09-10
基金资助
辽宁省自然科学基金（No.20102126）资助项目.
Synthesis and Cdc25B/PTP1B Inhibitory Activity Evaluation of Novel Acylhydrazone Derivatives Containing Carbazole Moity
Received date: 2018-06-27
Revised date: 2018-08-22
Online published: 2018-09-10
Supported by
Project supported by the Natural Science Foundation of Liaoning Province (No. 20102126).
以咔唑和4-氰基氯化苄为初始原料，经多步反应合成出了一系列新型含咔唑基团的酰腙衍生物6，并利用IR、1H NMR、13C NMR和元素分析对其进行了结构表征.对目标化合物进行了Cdc25B/PTP1B抑制活性评价，结果显示，目标化合物6对Cdc25B/PTP1B均具有较高的抑制活性，其中4-[（咔唑-9-基）甲基]-N'-（2-羟基-1-萘亚甲基）苯甲酰肼（6g）对Cdc25B和PTP1B的抑制活性最高，IC50值分别为（2.16±0.38）和（1.06±0.23）μg/mL.对化合物6g进行分子对接的研究结果表明，6g能与Cdc25B/PTP1B酶形成稳定的复合物，形成氢键和疏水等相互作用.
关键词： 酰腙; 咔唑; 合成; Cdc25B和PTP1B抑制剂; 分子对接
李英俊 , 王思远 , 靳焜 , 高立信 , 盛丽 , 张楠 , 刘季红 , 李佳 . 新型含咔唑环酰腙衍生物的合成及Cdc25B/PTP1B抑制活性评价[J]. 有机化学, 2019 , 39(2) : 491 -499 . DOI: 10.6023/cjoc201806042
A series of novel acylhydrazone derivatives 6 containing carbazole moity were synthesized by carbazole and 4-cyanobenzyl chloride as starting materials via multi-step reactions. Their structures were characterized by IR, 1H NMR, 13C NMR spectra and elemental analysis. All synthesized target compounds were evaluated for the inhibitory activities against Cdc25B and PTP1B. The results show that the target compounds display significant inhibitory activities against Cdc25B/PTP1B. Among them, compound 4-((carbazol-9-yl)methyl)-N'-(2-hydroxy-1-naphthalenylmethylene)benzoyl hydrazide (6g) had the highest inhibitory activities against Cdc25B and PTP1B with IC50 values of (2.16±0.38) and (1.06±0.23) μg/mL, respectively. The molecular docking results indicated that the hydrogen bond and hydrophobic interaction formed between compound 6g and Cdc25B/PTP1B enzyme.
Key words： acylhydrazone; carbazole; synthesis; Cdc25B and PTP1B inhibitor; molecular docking
[1] Ommis, V.; Demurtas, M.; Deplano, A.; Balboni, G.; Baldisserotto, A.; Manfredini, S.; Pacifico, S.; Liekens, S.; Balzarini, J. Molecules 2016, 21, 579.
[2] Temirak, A.; Shaker, Y. M.; Ragab, F. A. F.; Ali, M. M.; Soliman, S. M.; Mortier, J.; Wolber, G.; Ali, H. I.; Diwani, H. I. E. Arch. Pharm. Chem. Life Sci. 2014, 347, 291.
[3] Wu, D. Y.; Jin, F. F.; Lu, W. Q.; Zhu, J.; Li, C.; Wang, W.; Tang, Y.; Jiang, H. L.; Huang, J.; Liu, G. X.; Li, J. Chem. Biol. Drug Des. 2012, 79, 897.
[4] Taha, M.; Ismail, N. H.; Jamil, W.; Rashwan, H.; Kashif, S. M.; Sain, A. A.; Adenan, M. I.; Anouar, E. H.; Ali, M.; Rahim, F.; Khan, K. M. Eur. J. Med. Chem. 2014, 84, 731.
[5] Bouhadir, K. H.; Koubeissi, A.; Mohsen, F. A.; El-Harakeh, M. D.; Cheaib, R.; Younes, J.; Azzi, G.; Eid, A. A. Bioorg. Med. Chem. Lett. 2016, 26, 1020.
[6] Uppal, G.; Bala, S.; Kamboj, S.; Saini, M. Pharma Chem. 2011, 3, 250.
[7] He, H.; Xia, H.; Xia, Q.; Ren, Y.; He, H. Bioorg. Med. Chem. 2017, 25, 5652.
[8] Feng, Y. X.; Xue, L. W.; Zhang, C. X. J. Chil. Chem. Soc. 2014, 59, 2555.
[9] Maddela S.; Ajitha M.; Venugopal M.; Maddela R. Int. J. Pharm. Pharm. Sci. 2014, 6, 254.
[10] Kumar, V.; Basavarajaswamy, G.; Rai, M. V.; Poojary, B.; Pai, V. R.; Shruthi, N.; Bhat, M. Bioorg. Med. Chem. Lett. 2015, 25, 1420.
[11] Mentese, E.; Bekircan, O.; Islamoglu, F.; Beris, F. S. Rev. Chim. (Bucharest, Rom.) 2015, 66, 25.
[12] Burgeson, J. R.; Gharaibeh, D. N.; Moore, A. L.; Larson, R. A.; Amberg, S. M.; Bolken, T.; Hruby, D. E.; Dai, D. C. Bioorg. Med. Chem. Lett. 2013, 23, 5840.
[13] Eldehna, W. M.; Fares, M.; Abdel-Aziz, M. M.; Abdel-Aziz, H. A. Molecules 2015, 20, 8800.
[14] Velezheva, V.; Brenman, P.; Ivanov, P.; Kornienko, A.; Lyubimov, S.; Kazarian, K.; Nikonenko, B.; Majorov, K.; Apt, A. Bioorg. Med. Chem. Lett. 2016, 26, 978.
[15] Torre, S. M. D. D. L.; Vázquez C.; González-Chávez, Z.; Yépez-Mulia, L.; Nieto-Meneses, R.; Jasso-Chávez, R.; Saavedra, E.; Hernández-Luis, F. Bioorg. Med. Chem. Lett. 2017, 27, 3403.
[16] Murali, K.; Sparkes, H. A.; Prasad, K. J. R. Eur. J. Med. Chem. 2017, 128, 319.
[17] Sun, L. Q.; Wu, Y. B.; Liu, Y. H.; Chen, X. F.; Hu, L. X. Bioorg. Med. Chem. Lett. 2017, 27, 261.
[18] Kato, A.; Nagatsuka, Y.; Hitratsuka, T.; Kiuchi, S.; Iwase, Y.; Okuno, Y.; Tsukamoto, T.; Kiran, Y. B.; Sakai, N.; Konakahara, T. Tetrahedron 2016, 72, 4258.
[19] Mahapatra, D. K.; Das, D.; Shivhare, R. Int. J. Pharm. Sci. Drug Res. 2017, 9, 139.
[20] Itoh, T.; Hatae, N.; Nishiyama, T.; Choshi, T.; Hibino, S.; Yoshimura, T.; Ishikura, M. Med. Chem. Res. 2017, 128, 319.
[21] Arun, A.; Patel, O. P. S.; Saini, D.; Yadav, P. P.; Konwar, R. Biomed. Pharmacother. 2017, 93, 510.
[22] Wang, G. C.; Wang, J.; He, D. X.; Li, X.; Li, J.; Peng, Z. Y. Bioorg. Med. Chem. Lett. 2016, 26, 2806.
[23] Iqbal, S.; Khan, M. A.; Javaid, K.; Sadiq, R.; Fazal-ur-Rehman, S.; Choudhary, M. I.; Basha, F. Z. Bioorg. Chem. 2017, 74, 72.
[24] Börger, C.; Brütting, C.; Julich-Gruner, K. K.; Hesse, R.; Kumar, P.; Kutz, S. K.; Rönnefahrt, M.; Thomas, C.; Wan, B. J.; Franzblau, S. G. Bioorg. Med. Chem. 2017, 25, 6167.
[25] Chirke, S. S.; Krishna, J. S.; Rathod, B. B.; Bonam, S. R.; Khedkar, V. M.; Rao, B. V.; Kumar, H. M. S.; Shetty, P. R. Med. Chem. Drug Discovery 2017, 2, 7309.
[26] Kong, X. Q.; Zhang, H. Z.; Cao, C. S.; Zhou, S. L.; Pang, G. S.; Shi, Y.-H. Bioorg. Med. Chem. 2016, 24, 1376.
[27] Sadiq, Z.; Akbar, E.; Naz, A. N. Int. J. Pharma Bio Sci. 2014, 5, 455.
[28] Salih, N.; Salimon, J.; Yousif, E. Arabian J. Chem. 2016. 9, S781.
[29] Wang, P.-Y.; Fang, H.-S.; Shao, W.-B.; Zhou, J.; Chen, Z.; Song, B.-A.; Yang, S. Bioorg. Med. Chem. Lett. 2017, 27, 4294.
[30] Clausen, J. D.; Kjellerup, L.; Cohrt, K. O.; Hansen, J. B.; Dalby-Brown, W.; Winther, A. M. Bioorg. Med. Chem. Lett. 2017, 27, 4564.
[31] Wang, W. S.; Li, Q.; Wei, Y. F.; Xue, J.; Sun, X.; Yu, Y.; Chen, Z.; Li, S. Z.; Duan, L.-P. Int. J. Parasitol.:Drugs Drug Resist. 2017, 7, 191.
[32] Wang, W. S.; Li, J.; Yao, J. M.; Wang, T.; Li, S. Z.; Zheng, X. T.; Duan, L. P.; Zhang, W.-B. J. Antimicrob. Chemother. 2017, 72, 3122.
[33] Rostom, S. A. F.; Badr, M. H.; Razik, H. A. A. E.; Ashour, H. M. A. Eur. J. Med. Chem. 2017, 139, 263.
[34] Sarkis, M.; Miteva, M. A.; Lang, M. C. D.; Jaouen, M.; Sari, M. A.; Galcéra, M. O.; Ethève-Quelquejeu, M.; Garbay, C.; Bertho, G.; Braud, E. Proteins:Struct., Funct., Bioinf. 2013, 21, 7165.
[35] Lavecchia, A.; Cosconati, S.; Limongelli, V.; Novellino, E. ChemMedChem 2006, 1, 540.
[36] Wang, G. C.; Chen, M.; Qiu, J.; Xie, Z. Z.; Cao, A. B. Bioorg. Med. Chem. Lett. 2018, 28, 113.
[37] Lavecchia, A.; Coluccia, A.; Giovanni, C. D.; Novellino, E. Anticancer Agents Med. Chem. 2008, 8, 843.
[38] Ge, Y.; Kamp, M. V. D.; Malaisree, M.; Liu, D.; Liu, Y.; Mulholland, A. J. J. Comput.-Aided Mol. Des. 2017, 31, 995.
[39] Cai, J. Y.; Zhao, L.; Tao, W. Y. Pharm. Biol. 2015, 53, 1030.
[40] Li, Y. J.; Yu, Y.; Jin, K.; Gao, L. X.; Luo, T. C.; Sheng, L.; Shao, X.; Li, J. Bioorg. Med. Chem. Lett. 2014, 24, 4125.
[41] Li, Y.-J.; Shi, X.-L.; Gao, L.-X.; Jin, K.; Sheng, L.; Wu, J.-H.; Peng, L.-N.; Li, J. Chin. J. Org. Chem. 2015, 35, 191(in Chinese). (李英俊, 史相玲, 高立信, 靳焜, 盛丽, 吴疆红, 彭丽娜, 李佳, 有机化学, 2015, 35, 191.)
[42] Li, Y.-J.; Yu, Y.; Jin, K.; Gao, L.-X.; Luo, T.-C.; Sheng, L.; Shao, X.; Li, J. Chin. J. Org. Chem. 2015, 35, 129(in Chinese). (李英俊, 于洋, 靳焜, 高立信, 罗潼川, 盛丽, 邵欣, 李佳, 有机化学, 2015, 35, 129.)
[43] Li, Y.-J.; Li, J.-Y.; Peng, L.-N.; Gao, L.-X.; Jin, K.; Sheng, L.; Zhang, N.; Wang, S.-Y.; Li, J. Chin. J. Org. Chem. 2017, 37, 485(in Chinese). (李英俊, 李继阳, 彭丽娜, 高立信, 靳焜, 盛丽, 张楠, 王思远, 李佳, 有机化学, 2017, 37, 485.)
[44] Li, Y.-J.; Wang, S.-Y.; Jin, K.; Gao, L.-X.; Sheng, L.; Zhang, N.; Yang, K.-D.; Zhao, Y.; Li, J. Chin. J. Org. Chem. 2018, 38, 1242(in Chinese). (李英俊, 王思远, 靳焜, 高立信, 盛丽, 张楠, 杨凯栋, 赵月, 李佳, 有机化学, 2018, 38, 1242.)
[45] Kahveci, B.; Y?lmaz, F.; Mente?e, E.; Özil, M.; Karao?lu, ?. A. J. Heterocycl. Chem. 2014, 51, 982.
[46] Bayrak, H.; Demirbas, A.; Karaoglu, S. A.; Demirbas, N. Eur. J. Med. Chem. 2009, 44, 1057.
[47] Zhou, M.; Eun, Y. J.; Guzei, I. A.; Weibel, D. B. ACS Med. Chem. Lett. 2013, 4, 880.
[48] Li, Y.-J.; Li, J.-Y.; Jin, K.; Cao, X. Chin. J. Magn. Reson. 2017, 34, 25(in Chinese). (李英俊, 李继阳, 靳焜, 曹欣, 波谱学杂志, 2017, 34, 25.)
[49] Li, Y.-J.; Li, J.-Y.; Xu, Y.-T.; Jin, K.; Cao, X. Chin. J. Org. Chem. 2017, 37, 896(in Chinese). (李英俊, 李继阳, 许永廷, 靳焜, 曹欣, 有机化学, 2017, 37, 896.)
[50] Guo, D. C.; Li, P. L.; Wang, X.; Wang, L. Y.; Wu, P. L. Synth. Commun. 2010, 40, 3315.
[51] Li, Y.-J.; Sun, S.-Q. Semimicro Organic Chemistry Experiment, Chemical Industry Press, Beijing, 2009, pp. 114~115(in Chinese). (李英俊, 孙淑琴, 半微量有机化学实验, 化学工业出版社, 北京, 2009, pp. 114~115.)
[52] Li, Y.-J.; Zhang, N.; Jin, K.; Xu, Y.-T.; Wang, S.-Y.; Zhou, X.-X. Chin. J. Org. Chem. 2017, 37, 2640(in Chinese). (李英俊, 张楠, 靳焜, 许永廷, 王思远, 周晓霞, 有机化学, 2017, 37, 2640.)
[53] Huang, W. G.; Jiang, Y. Y.; Li, Q.; Li, J.; Li, J. Y.; Lu, W.; Cai, J. C. Tetrahedron 2005, 61, 1863.
[54] Sun, L. P.; Shen, Q.; Piao H. H.; Ma, W. P.; Gao, L. X.; Zhang, W.; Nan, F. J.; Li, J.; Piao, H. R. Eur. J. Med. Chem. 2011, 46, 3630.
/
| 〈 |
|
〉 |
